Noninvasive imaging and inhibition of human programmed death ligand 1 using nanobody K2 to improve cancer immunotherapy

Breckpot, K. (Speaker)

Activity: Talk or presentation › Talk or presentation at a workshop/seminar

Description

Seminar of the Melanoma Research Alliance

Period	15 Nov 2021
Held at	Laboratory of Molecullar and Cellular Therapy
Degree of Recognition	International

Related content

Projects
Nanobody-mediated Immune CHEchpoint imaging and inhibition (NICHE)
Project: Fundamental
Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Project: Fundamental
Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints
Project: Fundamental
NICHE: Nanobody-mediated Immune CHEckpoint imaging and inhibition
Project: Fundamental
Development of novel anti-checkpoint strategies based on nanobodies.
Project: Fundamental
IWT711 NICHE: Nanobody-mediated Immune CHEckpoint Imaging and inhibition
Project: Fundamental